微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -14.2% | -1744.16% | 84.62% | 141/158 | -0.37% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | -92.33% | -375.68% | -498.77% | 147/158 | -9.52% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | -15.42% | -1252.63% | -97.69% | 143/158 | 4.23% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | -7.8% | -84.83% | -912.99% | 135/158 | 2.66% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | -0.77% | -450% | 96.03% | 122/158 | 2.32% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | -19.41% | -69.96% | -1602.63% | 134/158 | -1.03% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | -1.14% | 64.15% | 72.99% | 120/158 | 2.34% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | -4.22% | -47.04% | -2018.18% | 125/158 | 1.46% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 0.22% | 126.51% | 101.93% | 114/158 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | -11.42% | 74.74% | -259.12% | 126/158 | 0.67% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | -3.18% | 77.86% | -10.8% | 121/158 | 2.8% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | -2.87% | 55.64% | -245.78% | 127/158 | 2.16% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | -0.83% | 80.1% | 98.16% | 121/158 | 1.57% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | -45.21% | -116.63% | -214.83% | 142/158 | 0.75% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | -14.36% | -3439.54% | -121.95% | 127/158 | 4.43% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | -6.47% | -168.46% | -55.16% | 133/158 | 2.94% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | -4.17% | -81.3% | 80.02% | 122/158 | 2.49% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | -20.87% | -50.69% | -4953.49% | 130/158 | 3.58% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 0.43% | -83.52% | 117.84% | 96/158 | 3.03% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | -2.41% | -289.76% | -4.78% | 113/158 | 4.19% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | -2.3% | -253.33% | 83.39% | 105/158 | 2.19% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | -13.85% | -138400% | -630.65% | 125/158 | 2.53% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 2.61% | -46.41% | 105.51% | 90/158 | 7.48% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 1.27% | 98.44% | -15.33% | 94/158 | 4.96% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 1.5% | -0.66% | 15100% | 69/158 | 2.41% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | -0.01% | 97.83% | -100.21% | 119/158 | 6.99% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 4.87% | 50.77% | 660.94% | 69/158 | 7.18% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 0.64% | -41.82% | -57.62% | 99/158 | 4.6% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 1.51% | 24.79% | 428.26% | 66/158 | 2.54% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | -0.46% | -114.84% | -114.24% | 118/158 | 9.61% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 3.23% | -48.24% | 193.64% | 76/158 | 8.29% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 1.1% | -69.36% | -9.09% | 93/158 | 5.58% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 1.21% | -52.36% | -60.97% | 59/158 | 2.09% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 3.1% | -55.01% | -50.32% | 90/158 | 6.19% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 6.24% | -43.12% | 73.82% | 43/158 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 3.59% | -24.74% | 41.34% | 53/158 | 3.48% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 2.54% | -26.38% | -63.13% | 32/158 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | 6.89% | -8.26% | -37.19% | 62/158 | 11.27% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 10.97% | 1.95% | 129.98% | 21/158 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | 4.77% | 0.21% | 38.26% | 36/158 | 4.87% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | 3.45% | 22.34% | -54.06% | 20/158 | 2.41% | 华东医药 | 26.63% | 行业排名> |